Treatment of Attention Deficit Hyperactivity Disorder in Preschool-Age Children (PATS)

• Status: Completed
• Trial end date: 2006-11-30
• Target enrollment: 0
• Participant gender: All

Summary

This research focuses on the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in very young children. The medication being used is methylphenidate (Ritalin); it is being studied to determine its safety and how well it works to treat ADHD in preschool-age children (3-5.5 year olds).

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: New York State Psychiatric Institute
• Collaborator: National Institute of Mental Health (NIMH)
• Treatments: Methylphenidate

Criteria

Boys and girls who are:

• Between the ages of 3-5.5 years

• Qualified as having ADHD by our diagnostic evaluations and clinical staff

• Otherwise generally healthy

• Willing, and have parents that are willing, to attend all visits required by the study

• Enrolled in some type of day-program: day care, preschool, nursery school, kindergarten, for at least 2 half days/week

• In classrooms with teachers that are willing to participate by completing rating scale